Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 247.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 247.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 247.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 247.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\29140979
.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117 PLoS+One
2017 ; 12
(11
): e0186520
Nephropedia Template TP
gab.com Text
Twit Text FOAVip
Twit Text #
English Wikipedia
Ginsenoside Rg3 inhibits angiogenesis in a rat model of endometriosis through the
VEGFR-2-mediated PI3K/Akt/mTOR signaling pathway
#MMPMID29140979
Cao Y
; Ye Q
; Zhuang M
; Xie S
; Zhong R
; Cui J
; Zhou J
; Zhu Y
; Zhang T
; Cao L
PLoS One
2017[]; 12
(11
): e0186520
PMID29140979
show ga
OBJECTIVE: This study aimed to investigate the link between the inhibitory effect
of ginsenoside Rg3 on the ectopic endometrium growth and the VEGFR-2-mediated
PI3K/Akt/mTOR signaling pathway, a mechanism known to inhibit angiogenesis and
induce ectopic endometrial cell apoptosis. MATERIALS AND METHODS: A model of
endometriosis was established by allotransplantation in rats. The rats were
randomly divided into 5 groups: the ginsenoside Rg3 low-dose group (group
A,5mg/kgBW/d of ginsenoside Rg3), the ginsenoside Rg3 high-dose group (group B,
10mg/kgBW/d of ginsenoside Rg3), the gestrinone group (group C, 0.5mg/kgBW/d of
gestrinone), the control group (groupD, 10ml/kg BW/d of 0.5%CMC-Na) and the
ovariectomized group (group E, 10ml/kgBW/d of 0.5%CMC-Na). Rats were executed
after 21 days of continuous administration. The ectopic endometrium volume was
measured and the inhibitory rate was calculated. The levels of serum estradiol
(E2) and progesterone (P) were detected by Electro-Chemiluminescence Immunoassay
(ECLI). The protein expressionof VEGF, VEGFR-2, p-Akt, and p-mTOR inthe ectopic
endometrium wastested by immunohistochemistry(IHC) and Western Blotting. The mRNA
expression levels of VEGF, VEGFR-2, Akt, and mTOR were tested by Real-Time
Polymerase Chain Reaction (PCR). The apoptosis rate of the ectopic endometrial
cells was detected by Terminal Deoxynucleotidyl Transferase-mediated
Digoxigenin-dUTP Nick-End Labeling Assay(TUNEL). MAIN RESULTS: Tissue
measurements revealed a dose-dependent inhibition effect of ginsenoside Rg3 on
the growth of the ectopic endometrium in treated rats compared to controls.
Immunohistochemical and Western Blotting assays confirmed that the expression of
VEGF, p-Akt, and p-mTOR was down-regulated in ginsenoside Rg3 -treated lesions.
Real-time PCR results also showed that the mRNA expression levels of VEGF, Akt,
and mTOR in the ectopic endometrium were reduced. CONCLUSIONS: The present study
demonstrates, for the first time, that ginsenoside Rg3 suppresses angiogenesis in
developing endometrial lesions. The ginsenoside Rg3 inhibitory effect on the
growth of the ectopic endometrium in EMs rats might occur through the blocking of
the VEGFR-2-mediated PI3K/Akt/mTOR signaling pathway, thus halting angiogenesis
and promoting the apoptosis of ectopic endometrial cells.
|*Disease Models, Animal
[MESH]
|Angiogenesis Inhibitors/pharmacology/therapeutic use
[MESH]
|Animals
[MESH]
|Blotting, Western
[MESH]
|Dose-Response Relationship, Drug
[MESH]
|Endometriosis/*drug therapy/pathology
[MESH]
|Endometrium/drug effects/pathology
[MESH]
|Estrogens/blood
[MESH]
|Female
[MESH]
|Ginsenosides/pharmacology/*therapeutic use
[MESH]